Table 2.
The differences between patients with and without bone metastases.
| Clinical factors | BM* (n) | NBM** (n) | P |
|---|---|---|---|
| Gender | 0.344 | ||
| Man | 343 | 1126 | |
| Female | 140 | 412 | |
| Age (years) | 0.013 | ||
| <60 | 244 | 678 | |
| ≥60 | 239 | 860 | |
| Histopathology | <0.001 | ||
| Adenocarcinoma | 300 | 585 | |
| Squamous cell carcinoma | 103 | 598 | |
| Small Cell Lung Cancer (SCLC) | 40 | 213 | |
| Poorly differentiated | 15 | 55 | |
| Large cell carcinoma | 4 | 13 | |
| Adenosquamous carcinoma | 3 | 9 | |
| Others | 18 | 65 | |
| CA-125 (U/ml) | <0.001 | ||
| <35 | 217 | 845 | |
| ≥35 | 266 | 693 | |
| CA-199 (U/ml) | <0.001 | ||
| <27 | 242 | 945 | |
| ≥27 | 130 | 261 | |
| ALP (U/L) | <0.001 | ||
| <90 | 231 | 992 | |
| 90–140 | 151 | 398 | |
| >140 | 95 | 119 | |
*BM: bone metastases group; **NBM: non bone metastases group.